(IN BRIEF) Fresenius’ mAbxience has partnered with HP Inc. to co-develop an AI and digital-twin solution that can model and optimise biopharmaceutical manufacturing. The technology uses real plant data to simulate production scenarios, helping increase reliability, stabilise yields and shorten … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI collaboration, AI Collaboration Between mAbxience and HP Targets Smarter, Biopharma Innovation, bioprocess optimisation, biosimilars production, cell culture process, digital transformation, digital twin biomanufacturing, Fresenius, FutureFresenius strategy, HP Inc., industrial AI, León Spain, mAbxience, manufacturing efficiency, monoclonal antibodies, More Predictable Bioprocessing
(IN BRIEF) Merck has officially opened its first fully climate-neutral manufacturing facility in Cork, Ireland, with a €150 million investment that will create more than 200 jobs by 2028. The 3,000-square-meter site will produce advanced filtration devices essential for the … Read the full press release
Posted in Business, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Ireland, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged aseptic processing, Blarney Business Park, Carrigtwohill, cell therapies, climate-neutral manufacturing, CO2 reduction, Cork, filtration devices, gene therapies, Ireland, Jean-Charles Wirth, Life Science, Merck, Merck invests €150 million in Cork to launch first climate-neutral filter production site and create 200 jobs, Merck strengthens European supply resilience with new climate-neutral manufacturing hub in Cork, monoclonal antibodies, partnership, renewable electricity, SHAPE 2040 strategy, sustainability, tangential-flow filtration, vaccines, virus filtration, €150 million investment, €2 billion global expansion, €440 million Ireland investment
(IN BRIEF) At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featuring 13 abstracts across oral and poster presentations. The Company aims to demonstrate its progress in developing innovative … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, AZD6563, Benjamin Moutier, bronchiectasis, COVID-19, ESCMID Global 2025, Fluenz, FluMist, hMPV, immunizations, infectious diseases, Klebsiella pneumoniae, monoclonal antibodies, mRNA, MRSA, preclinical data, Pseudomonas aeruginosa, Real-World Data, respiratory viral infections, RSV, serious bacterial infections, Staphylococcus aureus, Vaccines & Immune Therapies, variant-agnostic threshold, Vienna
(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion of its Glasgow biosafety testing facility thus helping to accelerate quality testing and reduce turnaround time for its clients. The … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Archie Lovatt, biological medicines, biologics, biologics manufacturers, biopharmaceutical, Biosafety Center of Excellence, BSL-2 cabinets, cell culture, cell therapies, COVID-19 vaccine, drug development, ELISA, gene therapies, Glasgow, Good Laboratory Practices, Good Manufacturing Practices, laboratories, monoclonal antibodies, polymerase chain reaction, real-time PCR testing, SGS, vaccines, virus detection
A new drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton. It has shown great promise in pre-clinical models and will be available to patients with certain leukaemias and non-Hodgkin … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?